Cholinergic drugs play a pivotal role in pharmacodynamics by modulating the activity of the neurotransmitter acetylcholine within the body's cholinergic system. These drugs exert their effects by interacting with cholinergic receptors, namely muscarinic and nicotinic receptors. Muscarinic receptors are predominantly found in various organs, including the heart, smooth muscles, and glands, while nicotinic receptors are present in the neuromuscular junctions. Stimulation of muscarinic receptors by cholinergic drugs leads to diverse physiological responses, such as increased glandular secretion, smooth muscle contraction, and a decrease in heart rate. On the other hand, activation of nicotinic receptors results in neuromuscular transmission and subsequent skeletal muscle contraction. Pharmacodynamics of cholinergic drugs involve mimicking or enhancing the effects of acetylcholine, ultimately influencing processes like gastrointestinal motility, respiratory function, and cardiovascular regulation. Understanding these pharmacological dynamics is crucial for therapeutic applications, such as in the treatment of conditions like myasthenia gravis or for promoting gastrointestinal motility after surgery. However, careful consideration is required due to potential side effects, including bradycardia, bronchoconstriction, and gastrointestinal disturbances.
Title : Ectopically expressed olfactory receptors as an untapped family of drug targets and discovery of agonists and antagonists of OR51E1, an understudied G protein-coupled receptor
Vladlen Slepak, University of Miami Miller School of Medicine, United States
Title : Managing healthcare transformation towards personalized, preventive, predictive, participative precision medicine ecosystems
Bernd Blobel, University of Regensburg, Germany
Title : Analytical strategies for solid-state forms in drug development
Maria Cristina Gamberini, University of Modena e Reggio Emilia, Italy
Title : Understanding drug transport in plasma: The role of protein binding
Saad Tayyab, UCSI University, Malaysia
Title : Innovative development and delivery of biologics for chronic obstructive pulmonary disease
Yong Xiao Wang, Albany Medical College, United States
Title : Search for novel biomarkers and therapeutic targets for inflammatory disease
Madhav Bhatia, University of Otago, New Zealand
Title : Personalized and Precision Medicine (PPM) as a unique healthcare model through de-sign-inspired biotech- & biopharma-driven applications and upgraded business mar-keting to secure the human healthcare and biosafety
Sergey Suchkov, N.D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences & InMedStar, Russian Federation
Title : Design and evaluation of exo-itc: A bilayer fibrous system for controlled exosome delivery in dermatological applications
Luis Jesus Villarreal Gomez, FCITEC - Universidad AutĂłnoma de Baja California, Mexico
Title : Abuse-deterrent dosage form technique utilizing a fusion of innovative pharmaceuticals and ion exchange resin
Bhupendra Gopalbhai Prajapati, Parul University, India
Title : Macitentan/tadalafil combination– An additional value in pharmacotherapy of pulmonary arterial hypertension
Miroslav Radenkovic, University of Belgrade, Serbia